Additional information
White Powder
1391080-43-5
ACI-044411
96.2-96.7°C
C28H29BrN2O2
505.45
Ambient
2-8°C
Antimuscarinics
Pharmaceutical Impurity Standards
2-{1-[2-(7-bromo-2,3-dihydrobenzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenylacetamide
2-{1-[2-(7-bromo-2,3-dihydrobenzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenylacetamide
(3S)-1-[2-(7-Bromo-2,3-dihydro-5-benzofuranyl)ethyl]-?,?-diphenyl-3-pyrrolidineacetamide





![LINAGLIPTIN DIMER (25 mg) (N¹,N²-Bis{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-{(4-methylquinazolin-2-yl)methyl}-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}phthalamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)